Sanofi (NASDAQ:SNY) Stock, Unusual Options

Sanofi

NYSE

Overview

News

Earnings

Options

Guidance

Dividends

Analyst Ratings

Short Interest

Government Trades

Stock Report

Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for approximately 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.

Sanofi's Multiple Sclerosis Drug Faces Trial And Regulatory Setbacks

Comments

Sanofi Unusual Options